Tilmicosin enteric granules and premix to pigs: Antimicrobial susceptibility testing and comparative pharmacokinetics

Journal of Veterinary Pharmacology and Therapeutics
Jincheng XiongYinsheng Qiu

Abstract

The purpose of this study was to compare the pharmacokinetics and relative bioavailability of tilmicosin enteric granules and premix after oral administration at a dose of 40 mg/kg in pigs. Three kinds of different respiratory pathogens were selected for determination of minimal inhibitory concentration (MIC) to tilmicosin. Eight healthy pigs were assigned to a two-period, randomized crossover design. A modified rapid, sensitive HPLC method was used for determining the concentrations of tilmicosin in plasma. Pharmacokinetic parameters were calculated by using WinNonlin 5.2 software. The MIC90 of tilmicosin against Haemophilus parasuis, Actinbacillus pleuropneumoniae, and Pasteurella multocida were all 8 μg/ml. These results indicated that these common pig respiratory bacteria are sensitive to tilmicosin. The main parameters of time to reach maximum plasma concentration (Tmax ), elimination half-life (t1/2β ), mean residence time (MRT), and apparent volume of distribution (VF ) were 2.03 ± 0.37 hr, 29.31 ± 5.56 hr, 25.22 ± 2.57 hr, 4.06 ± 1.04 L/kg, and 3.05 ± 0.08 hr, 17.06 ± 1.77 hr, 15.55 ± 1.37 hr, 2.95 ± 0.62 L/kg after the orally administrated tilmicosin enteric granules and premix. The relative bioavailability of tilmicos...Continue Reading

References

Apr 1, 1978·Journal of Pharmacokinetics and Biopharmaceutics·K YamaokaT Uno
Oct 1, 1995·Journal of Veterinary Pharmacology and Therapeutics·G ZivA Saran
Jan 1, 1997·Research in Veterinary Science·A Ramadan
Sep 10, 1998·Journal of Veterinary Pharmacology and Therapeutics·B Scorneaux, T R Shryock
Jan 14, 1999·Journal of Veterinary Pharmacology and Therapeutics·S ModricH Derendorf
Dec 7, 2000·Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·D C DeRosaT R Shryock
Nov 9, 2002·Journal of Veterinary Pharmacology and Therapeutics·G ChristodoulopoulosG C Fthenakis
Aug 6, 2003·Preventive Veterinary Medicine·A G J VelthuisJ H M Verheijden
Apr 29, 2004·Journal of Agricultural and Food Chemistry·Yue ZhangJunlin Guo
Jul 13, 2005·American Journal of Veterinary Research·Jianzhong ShenXiaowei Li
Jan 17, 2007·Veterinary Research Communications·E A Abu-BashaA F Al-Shunnaq
Feb 18, 2011·Journal of Veterinary Pharmacology and Therapeutics·K R LombardiR P Hunter
Nov 2, 2018·The Journal of Veterinary Medical Science·Jincheng XiongYinsheng Qiu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.